About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.23 (-2.13%)
DXB ASX Dimerix Ltd
Carregando status da lista de acompanhamento…
Dimerix Ltd share price
DXB price activity
Último preço
$ 0,230
Variação (24h)
-0,01 AUD (-2,13%)
Volume
975.41K
Volume (média 4 sem.)
-
Abertura
$ 0,24
Variação do dia
$ 0,23 - $ 0,24
Fechamento anterior
$ 0,24
Último negócio
06 Oct, 5:10 am GMT+0
Atrasado
06 Oct, 5:10 am GMT+0
DXB price performance
0%
5D
-19,3%
1M
-58,18%
YTD
-56,19%
1Y
Atrasado
06 Oct, 5:10 am GMT+0
quote.marketSignals